Literature DB >> 2051738

Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis.

H L Li1, W W Hancock, J P Dowling, R C Atkins.   

Abstract

We recently reported evidence for the involvement of local cellular immune activation in the immunopathogenesis of human IgA nephropathy, particularly in cases of IgA disease featuring crescent formation. In the current study, using monoclonal antibodies, we investigated whether mononuclear cells bearing receptors for interleukin 2 (IL-2R+ MNC) were present within glomeruli or associated crescents in biopsies from patients with crescentic glomerulonephritis (greater than 60% crescents, N = 19), IgA disease with crescents (N = 9), or other types of proliferative glomerulonephritis with crescents (10 to 44%, N = 6), compared with normal control kidneys (N = 10). Biopsies were further classified into those showing active (cells, fibrin) (N = 15) or inactive (sclerosed) crescents (N = 19), to determine whether IL-2R+ MNC were particularly associated with active crescent formation. Few leucocytes were found within glomerular tufts of normal kidneys (2.4 +/- 0.7 cells/glomerular cross-section; mean +/- SEM). By contrast, in biopsies from patients with active crescentic glomerulonephritis, total intraglomerular tuft leucocytes were increased to 14.0 +/- 1.7 (P less than 0.01 vs. normal kidneys), largely due to increased numbers of intraglomerular monocytes (10.4 +/- 1.1, P less than 0.01) and T cells (3.7 +/- 0.6, P less than 0.01). Biopsies with active crescents also contained significantly increased numbers of intraglomerular tuft IL-2R+ MNC (4.0 +/- 0.7, 29% of total intraglomerular leucocytes), and there was a strong correlation between the numbers of intraglomerular IL-2R+ MNC and T cells (P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051738     DOI: 10.1038/ki.1991.97

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis.

Authors:  Jean Wu; John Hicks; Jason Borillo; William F Glass; Ya-Huan Lou
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil.

Authors:  Andrew S O'Connor; Farhad Navab; Michael J Germain; Jonathan K Freeman; Jeffrey G Mulhern; Michael H O'Shea; George S Lipkowitz; Robert L Madden; Gregory L Braden
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

Review 3.  Tissue factor in crescentic glomerulonephritis.

Authors:  R T McCluskey
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

4.  Trafficking of inflammatory macrophages from the kidney to draining lymph nodes during experimental glomerulonephritis.

Authors:  H Y Lan; D J Nikolic-Paterson; R C Atkins
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

Review 5.  Immunopathogenesis of experimental IgA nephropathy.

Authors:  A Rifai
Journal:  Springer Semin Immunopathol       Date:  1994

Review 6.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

7.  IFNgamma induces functional chemokine receptor expression in human mesangial cells.

Authors:  M Schwarz; M Wahl; K Resch; H H Radeke
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

8.  Expression of lymphotactin mRNA in experimental crescentic glomerulonephritis.

Authors:  Y Natori; Z L Ou; Y Yamamoto-Shuda; Y Natori
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  Interleukin-2 receptor expression on blood monocytes of patients with multiple sclerosis.

Authors:  M Zaffaroni; A Ghezzi; L Callea; A Zibetti
Journal:  Ital J Neurol Sci       Date:  1992-11

Review 10.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.